Ad
related to: Pharmaceutical Drug Companies and Biotech Companies
Search results
NewVale, an unorthodox investment firm, sets out to support biotech’s ‘infrastructure’
BioPharma Dive via Yahoo Finance· 3 days agoThe firm, which closed a $167 million fund, aims to fill a “crucial gap” by growing the companies...
How Viking Therapeutics Stock Could 30x
The Motley Fool via AOL· 3 days agoI do not believe this is a blue-sky scenario in the least. If VK2735 can continue to post top levels of efficacy and safety, I suspect this mid-cap ...
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
The Motley Fool via AOL· 2 days agoCRISPR Therapeutics CRISPR...biotechnology stock that has been turning heads recently. The company...
Microdosing For Depression: Psychedelics Biotech Signs $66.5M Non-Binding Deal To Out-License Novel...
Benzinga· 2 days agoThe news comes on the heels of Enveric entering into a non-binding term sheet with an undisclosed ...
SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer
The Pendulum· 6 days agoSN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track...
Biotech Behemoths: 3 Giants Set to Dominate the Health Scene
InvestorPlace· 2 days agoBiotechnology is an interesting place to look if you’re looking for growth and are not put off by...
Cytokinetics Reverses Higher On 'Pristine' Results For Bristol Myers-Rivaling Heart Drug
Investor's Business Daily· 1 day agoAs of Dec. 31, there...but lagged views for $100.2 million, according to FactSet. The drug's...
Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated
Zacks· 6 days agoThe year-over-year improvement can be attributed to higher revenues from Galafold (migalastat) sales and incremental revenues from the sale of the newly approved combo drug
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 21 hours agoNovo Holdings A/S ("Novo Holdings") today announced that it has agreed to acquire a majority stake in Single Use Support, a fast-growing life science tools company providing ...
Amphastar Pharmaceuticals (NASDAQ:AMPH) Upgraded to “Buy” by StockNews.com
ETF DAILY NEWS· 2 days agoJPMorgan Chase & Co. initiated coverage on Amphastar Pharmaceuticals in a research note on Tuesday, March 5th. Needham & Company LLC reaffirmed a hold rating ...
